APO RESEARCH · REPORT
Procalcitonin Antibody
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
Product & engineering
Understand the product.
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
Selected research
Market Structure
Global Procalcitonin Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
In China, Procalcitonin Antibody key players include Thermo Fisher, Wondfo , Ningbo Medicalsystem Biotechnology, bioMerieux, Snibe, etc. The top five players hold a share about 35%.
East China is the largest market, with a share about 25%, followed by South China and Southeast China, having a total share about 30 percent.
Read the full market overview
In terms of product, Monoclonal Procalcitonin Antibody is the largest segment, with a share about 90%. And in terms of application, the largest application is Hospital, followed by Medical research institutions, etc.
This report provides an overview of the global Procalcitonin Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Procalcitonin Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Procalcitonin Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Procalcitonin Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.
Procalcitonin Antibody Segment by Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
Procalcitonin Antibody Segment by Type
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Procalcitonin Antibody Segment by Application
Hospital
Medical research institutions
Others
Procalcitonin Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Procalcitonin Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Procalcitonin Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Procalcitonin Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Procalcitonin Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal Procalcitonin Antibody
- Monoclonal Procalcitonin Antibody
Applications
- Hospital
- Medical research institutions
- Others
Companies covered
- Thermo Fisher
- Roche Diagnostics
- bioMerieux
- HyTest
- Wondfo
- Ningbo Medicalsystem Biotechnology
- Snibe
- Vazyme Biotech
- Getein Biotech
- Hotgen Biotech
- Lumigenex
- Shanghai Medicine'nest Pharmaceutical
- Kitgen
- Beijing KeyGen
- Fantibody
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Procalcitonin Antibody Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Procalcitonin Antibody Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Procalcitonin Antibody Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Procalcitonin Antibody Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Procalcitonin Antibody Market Dynamics
- 2.1 Procalcitonin Antibody Industry Trends
- 2.2 Procalcitonin Antibody Industry Drivers
- 2.3 Procalcitonin Antibody Industry Opportunities and Challenges
- 2.4 Procalcitonin Antibody Industry Restraints
3 Procalcitonin Antibody Market by Manufacturers
- 3.1 Global Procalcitonin Antibody Revenue by Manufacturers (2021-2026)
- 3.2 Global Procalcitonin Antibody Sales by Manufacturers (2021-2026)
- 3.3 Global Procalcitonin Antibody Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Procalcitonin Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Procalcitonin Antibody Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Procalcitonin Antibody Manufacturers, Product Type & Application
- 3.7 Global Procalcitonin Antibody Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Procalcitonin Antibody Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Procalcitonin Antibody Players Market Share by Revenue in 2025
- 3.8.3 2025 Procalcitonin Antibody Tier 1, Tier 2, and Tier 3
4 Procalcitonin Antibody Market by Type
- 4.1 Procalcitonin Antibody Type Introduction
- 4.1.1 Polyclonal Procalcitonin Antibody
- 4.1.2 Monoclonal Procalcitonin Antibody
- 4.2 Global Procalcitonin Antibody Sales by Type
- 4.2.1 Global Procalcitonin Antibody Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Procalcitonin Antibody Sales by Type (2021-2032)
- 4.2.3 Global Procalcitonin Antibody Sales Market Share by Type (2021-2032)
- 4.3 Global Procalcitonin Antibody Revenue by Type
- 4.3.1 Global Procalcitonin Antibody Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Procalcitonin Antibody Revenue by Type (2021-2032)
- 4.3.3 Global Procalcitonin Antibody Revenue Market Share by Type (2021-2032)
5 Procalcitonin Antibody Market by Application
- 5.1 Procalcitonin Antibody Application Introduction
- 5.1.1 Hospital
- 5.1.2 Medical research institutions
- 5.1.3 Others
- 5.2 Global Procalcitonin Antibody Sales by Application
- 5.2.1 Global Procalcitonin Antibody Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Procalcitonin Antibody Sales by Application (2021-2032)
- 5.2.3 Global Procalcitonin Antibody Sales Market Share by Application (2021-2032)
- 5.3 Global Procalcitonin Antibody Revenue by Application
- 5.3.1 Global Procalcitonin Antibody Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Procalcitonin Antibody Revenue by Application (2021-2032)
- 5.3.3 Global Procalcitonin Antibody Revenue Market Share by Application (2021-2032)
6 Global Procalcitonin Antibody Sales by Region
- 6.1 Global Procalcitonin Antibody Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Procalcitonin Antibody Sales by Region (2021-2032)
- 6.2.1 Global Procalcitonin Antibody Sales by Region (2021-2026)
- 6.2.2 Global Procalcitonin Antibody Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Procalcitonin Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Procalcitonin Antibody Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Procalcitonin Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Procalcitonin Antibody Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Procalcitonin Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Procalcitonin Antibody Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Procalcitonin Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Procalcitonin Antibody Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Procalcitonin Antibody Revenue by Region
- 7.1 Global Procalcitonin Antibody Revenue by Region
- 7.1.1 Global Procalcitonin Antibody Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Procalcitonin Antibody Revenue by Region (2021-2026)
- 7.1.3 Global Procalcitonin Antibody Revenue by Region (2027-2032)
- 7.1.4 Global Procalcitonin Antibody Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Procalcitonin Antibody Revenue (2021-2032)
- 7.2.2 North America Procalcitonin Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Procalcitonin Antibody Revenue (2021-2032)
- 7.3.2 Europe Procalcitonin Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Procalcitonin Antibody Revenue (2021-2032)
- 7.4.2 Asia-Pacific Procalcitonin Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Procalcitonin Antibody Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Procalcitonin Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher
- 8.1.1 Thermo Fisher Company Information
- 8.1.2 Thermo Fisher Business Overview
- 8.1.3 Thermo Fisher Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Procalcitonin Antibody Product Portfolio
- 8.1.5 Thermo Fisher Recent Developments
- 8.2 Roche Diagnostics
- 8.2.1 Roche Diagnostics Company Information
- 8.2.2 Roche Diagnostics Business Overview
- 8.2.3 Roche Diagnostics Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Roche Diagnostics Procalcitonin Antibody Product Portfolio
- 8.2.5 Roche Diagnostics Recent Developments
- 8.3 bioMerieux
- 8.3.1 bioMerieux Company Information
- 8.3.2 bioMerieux Business Overview
- 8.3.3 bioMerieux Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 bioMerieux Procalcitonin Antibody Product Portfolio
- 8.3.5 bioMerieux Recent Developments
- 8.4 HyTest
- 8.4.1 HyTest Company Information
- 8.4.2 HyTest Business Overview
- 8.4.3 HyTest Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 HyTest Procalcitonin Antibody Product Portfolio
- 8.4.5 HyTest Recent Developments
- 8.5 Wondfo
- 8.5.1 Wondfo Company Information
- 8.5.2 Wondfo Business Overview
- 8.5.3 Wondfo Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Wondfo Procalcitonin Antibody Product Portfolio
- 8.5.5 Wondfo Recent Developments
- 8.6 Ningbo Medicalsystem Biotechnology
- 8.6.1 Ningbo Medicalsystem Biotechnology Company Information
- 8.6.2 Ningbo Medicalsystem Biotechnology Business Overview
- 8.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Product Portfolio
- 8.6.5 Ningbo Medicalsystem Biotechnology Recent Developments
- 8.7 Snibe
- 8.7.1 Snibe Company Information
- 8.7.2 Snibe Business Overview
- 8.7.3 Snibe Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Snibe Procalcitonin Antibody Product Portfolio
- 8.7.5 Snibe Recent Developments
- 8.8 Vazyme Biotech
- 8.8.1 Vazyme Biotech Company Information
- 8.8.2 Vazyme Biotech Business Overview
- 8.8.3 Vazyme Biotech Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Vazyme Biotech Procalcitonin Antibody Product Portfolio
- 8.8.5 Vazyme Biotech Recent Developments
- 8.9 Getein Biotech
- 8.9.1 Getein Biotech Company Information
- 8.9.2 Getein Biotech Business Overview
- 8.9.3 Getein Biotech Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Getein Biotech Procalcitonin Antibody Product Portfolio
- 8.9.5 Getein Biotech Recent Developments
- 8.10 Hotgen Biotech
- 8.10.1 Hotgen Biotech Company Information
- 8.10.2 Hotgen Biotech Business Overview
- 8.10.3 Hotgen Biotech Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hotgen Biotech Procalcitonin Antibody Product Portfolio
- 8.10.5 Hotgen Biotech Recent Developments
- 8.11 Lumigenex
- 8.11.1 Lumigenex Company Information
- 8.11.2 Lumigenex Business Overview
- 8.11.3 Lumigenex Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Lumigenex Procalcitonin Antibody Product Portfolio
- 8.11.5 Lumigenex Recent Developments
- 8.12 Shanghai Medicine'nest Pharmaceutical
- 8.12.1 Shanghai Medicine'nest Pharmaceutical Company Information
- 8.12.2 Shanghai Medicine'nest Pharmaceutical Business Overview
- 8.12.3 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Product Portfolio
- 8.12.5 Shanghai Medicine'nest Pharmaceutical Recent Developments
- 8.13 Kitgen
- 8.13.1 Kitgen Company Information
- 8.13.2 Kitgen Business Overview
- 8.13.3 Kitgen Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Kitgen Procalcitonin Antibody Product Portfolio
- 8.13.5 Kitgen Recent Developments
- 8.14 Beijing KeyGen
- 8.14.1 Beijing KeyGen Company Information
- 8.14.2 Beijing KeyGen Business Overview
- 8.14.3 Beijing KeyGen Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Beijing KeyGen Procalcitonin Antibody Product Portfolio
- 8.14.5 Beijing KeyGen Recent Developments
- 8.15 Fantibody
- 8.15.1 Fantibody Company Information
- 8.15.2 Fantibody Business Overview
- 8.15.3 Fantibody Procalcitonin Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Fantibody Procalcitonin Antibody Product Portfolio
- 8.15.5 Fantibody Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Procalcitonin Antibody Value Chain Analysis
- 9.1.1 Procalcitonin Antibody Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Procalcitonin Antibody Production Mode & Process
- 9.2 Procalcitonin Antibody Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Procalcitonin Antibody Distributors
- 9.2.3 Procalcitonin Antibody Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst